All posts in What is New in Hematology Oncology

FROM NEJM JOURNAL WATCH: July 3, 2014 Stem-Cell Transplantation for Middle-Aged Patients with Myelofibrosis David Green, MD, PhD Reviewing Rondelli D et al., Blood 2014 Jun 24; The benefits of allogeneic hematopoietic stem-cell transplantation outweigh the risks, but only with sibling donors. Myelofibrosis is a progressive disease that culminates in fatal cytopenias or leukemic transformation. […]